Dark

Check out our Level2View

NWBO
NORTHWEST BIOTHRPUTCS INC
stock OTC

EOD

May 15, 2025

0.2883USD+1.891%(+0.0054)2,115,524

Pre-market

Dec 31, 1969

0.00USD-100.000%(-0.28)0

After-hours

Dec 31, 1969

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Dec 21, 2021

09:31AM EST Northwest Biotherapeutics Announces MHRA Approval Of License For GMP Manufacturing At Sawston, UK Facility RTTNews

09:25AM EST Northwest Biotherapeutics Announces MHRA Approval Of License for GMP PR Newswire

Nov 29, 2021

10:39AM EST Northwest Biotherapeutics Announces $15 Million Financing PR Newswire

Oct 28, 2021

11:43AM EDT Northwest Biotherapeutics Announces HTA License Issued and MHRA Inspection PR Newswire

May 12, 2021

09:34AM EDT Northwest Biotherapeutics Says Application For Certification Of Manufacturing Facility In Sawston Submitted To MHRA RTTNews

09:17AM EDT UK Manufacturing Facility & Phase III Trial Updates From Northwest PR Newswire

Mar 16, 2021

09:31AM EDT Northwest Biotherapeutics Announces Development Completed for Initial PR Newswire

Oct 5, 2020

09:35AM EDT Northwest Biotherapeutics Announces Data Lock of Phase III Trial PR Newswire

Sep 1, 2020

10:08AM EDT Northwest Biotherapeutics Acquires Flaskworks PR Newswire

Aug 27, 2020

09:40AM EDT NW Bio Accelerating Sawston Plant Phase I Buildout PR Newswire

Aug 21, 2020

11:03AM EDT Northwest Biotherapeutics Announces $5 Million Financing PR Newswire

Aug 19, 2020

11:24AM EDT NW Bio Announces Completion of Further Data Gathering For Phase III Trial PR Newswire

Aug 11, 2020

11:57AM EDT Northwest Biotherapeutics Announces $8 Million Financing PR Newswire

Jul 24, 2020

09:33AM EDT Northwest Biotherapeutics Completes Phase 3 Trial Sites' Databases RTTNews

09:32AM EDT Northwest Biotherapeutics Announces Completion of Phase 3 Trial Sites' Databases PR Newswire

Share